ICDRA «Smart regulation: Delivering quality assured medical products for all»

On October 14-18, 2024 the 19th International Conference of Drug Regulatory Authorities (ICDRA) organized by India’s Central Drug Standard Control Organization (CDSCO) in collaboration with the World Health Organization was held in India, New Delhi. This year’s theme of the conference: «Smart regulation: Delivering quality assured medical products for all».

ICDRA provides a unique platform to support and guide regulators and WHO in confronting the challenges and highlighting the opportunities of the modern dynamic and innovative regulatory sector.

Head of the State Service of Ukraine on Medicines and Drugs Control Roman Isaienko discussed the issues of raw pharmaceutical materials quality, medical devices regulation (including in vitro diagnostic products): global, regional and national trends. During one of the plenary sessions, the topic of effective regulatory harmonization and convergence through regional/continental networks was discussed. The agenda also included issues of ensuring the quality and safety of medicines, including herbal medicines and homeopathy, with significant attention given to regulatory reform, the adoption of new technologies and electronic trade.

On the sidelines of the conference, Head of the State Service of Ukraine on Medicines and Drug Control, Mr. Roman Isaienko, held a meeting with the Director General of CDSCO, Dr. Rajeev Singh Raghuvanshi and his deputies. During the meeting, the representatives of the regulatory bodies discussed the practical steps for the implementation of the Memorandum of Understanding between the State Service of Ukraine on Medicines and Drugs Control and the Central Drugs Standard Control Organization of the Ministry of Health & Family Welfare of the Government of India signed on August 23, 2024 during the visit of the Prime Minister of India, H.E. Narendra Modi to Ukraine.

The meeting members agreed to coordinate joint actions to prevent the circulation of counterfeit and substandard medicines, exchange information on standards, legislation and regulations in the sphere of medicines and cosmetics, as well as exchange experience on practical issues related to the detection of substandard/falsified medicines.